ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Dyslipidemia"

  • 2020 American Transplant Congress

    The Impact of Sirolimus on Weight Gain Post Heart Transplant

    S. M. Gore, C. E. Raphael, K. Mara, C. Arendt, A. L. Clavell, S. A. Bernard

    Mayo Clinic, Rochester, MN

    *Purpose: Obesity is common after heart transplant (HT), resulting in increased risk of new onset diabetes, all-cause and cardiovascular mortality and graft failure. Immunosuppressants (ISN)…
  • 2019 American Transplant Congress

    Statin Underutilization in Patients Listed for Liver Transplant

    K. Mishra1, S. Naffouj1, S. Modi1, C. Dagher1, S. Gorgis1, D. Venkat2

    1Internal Medicine, Henry Ford Hospital, Detroit, MI, 2Transplant Hepatology, Henry Ford Hospital, Detroit, MI

    *Purpose: Current guidelines recommend statin use in high risk patients based on the ASCVD (atherosclerotic cardiovascular disease) score, diabetes, or LDL levels. Despite several trials…
  • 2019 American Transplant Congress

    Serum Apolipoproteins B and A1 Predict the Development of Late Post-Transplant Diabetes Mellitus in Prevalent Adult Kidney Transplant Recipients

    R. Malyala, L. Rapi, M. Nash, G. Prasad

    St Michael's Hospital, University of Toronto, Toronto, ON, Canada

    *Purpose: Post-transplant diabetes mellitus (PTDM) increases adverse outcomes. The risk factors for PTDM have not been fully delineated. Glucose metabolism links closely to cholesterol metabolism.…
  • 2019 American Transplant Congress

    Effects of Statin Use on Cardiovascular Outcome in Patients with Renal Transplantation

    J. Kim1, K. Park1, S. Park1, M. Yu2, Y. Kim1, K. Kim1, M. Park3, H. Lee1

    1Seoul National University Hospital, Seoul, Korea, Republic of, 2Hanyang University Guri Hospital, Gyeonggi-do, Korea, Republic of, 3Samsung Medical Center, Seoul, Korea, Republic of

    *Purpose: Cardiovascular disease is the main cause of death among patients with end-stage renal disease (ESRD). Statin, HMG-CoA reductase inhibitor, is well known to significantly…
  • 2019 American Transplant Congress

    Insulin Resistance as a Surrogate Marker for Post-Transplantation Diabetes Mellitus

    D. D. de Lucena, É. B. Rangel, J. R. de Sá, J. O. Medina-Pestana

    Department of Medicine, Division of Nephrology, Federal University of São Paulo, São Paulo, Brazil

    *Purpose: Post-transplantation diabetes mellitus (PTDM) adversely impact patient and kidney allograft survival. Further knowledge of the risk factors involved in the onset and progression of…
  • 2019 American Transplant Congress

    Consistent High Burden of Arteriosclerosis in Pediatric Kidney Transplant Recipients

    K. Ostendorf1, N. Memaran1, B. Borchert-Mörlins1, J. von der Born1, E. Bauer1, A. von Wick1, J. Oh2, M. J. Kemper3, R. Büscher4, B. M. Schmidt5, A. Melk1

    1Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany, 2Pediatric Nephrology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, 3Department of Pediatrics, Asklepios Klinik Nord - Heidberg, Hamburg, Germany, 4Pediatric Nephrology, University Hospital, Essen, Germany, 5Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany

    *Purpose: The second most common cause of death in pediatric kidney transplant (KT) recipients are cardiovascular (CV) diseases. We have previously shown that pulse wave…
  • 2018 American Transplant Congress

    Comparison of BMI, Waist Circumference and Waist-to-Height Ratio for Identification of Cardiovascular Risk in Pediatric Kidney Transplant Recipients

    K. Sgambat, S. Clauss, A. Moudgil.

    Children's National, Washington DC.

    Background: Children with kidney disease have altered body composition and short stature that may not be accurately assessed by standard methods. The measure of obesity…
  • 2018 American Transplant Congress

    Glucocorticoid Receptor Polymorphism Affects Susceptibility of Dyslipidemia in Recipients One Year after Kidney Transplantation

    K. Numakura,1 H. Kagaya,2 N. Komine,1 R. Yamamoto,1 N. Fujiyama,3 H. Tsuruta,1 A. Maeno,1 M. Saito,1 S. Narita,4 T. Inoue,1 T. Niioka,2 M. Miura,2 T. Habuchi,1 S. Satoh.3

    1Urology, Akita University Graduate School of Medicine, Akita, Japan; 2Pharmacy, Akita University Hospital, Akita, Japan; 3Center for Kidney Disease and Transplantation, Akita University Hospital, Akita, Japan; 4Blood Purification, Akita University Hospital, Akita, Japan.

    Purpose. Dyslipidemia (DL) is a critical comorbidity after renal transplantation and can arise cardiovascular diseases. The relationship between developing of DL and glucocorticoid receptor (NR3C1)…
  • 2018 American Transplant Congress

    Influence of mTOR Inhibitors on Metabolic Outcomes One Year after Kidney Transplantation: The Role of Pre-Transplantation Diabetes

    D. Cucchiari,1 S. Karam,2 P. Ventura-Aguiar,1 J. Torregrosa,1 F. Diekmann.1

    1Renal Transplant Unit, Hospital Clínic, Barcelona, Spain; 2Department of Medicine, Saint George Hospital, Beirut, Lebanon.

    INTRODUCTION: mTOR inhibitors alter lipids and carbohydrate metabolism in kidney transplant recipients. Little is known if there is any difference between patients who were already…
  • 2017 American Transplant Congress

    Statins in Liver Transplant Recipients: Rates of Use, Mortality and Rejection.

    R. Selim,1 A. Abdulhamid,1 A. Shyamraj,2 A. Watson,2 J. Tang,2 S.-M. Jafri.2

    1Internal Medicine, Henry Ford Hospital, Detroit, MI; 2Gastroenterology, Henry Ford Hospital, Detroit, MI

    Introduction:Liver transplant recipients are prone to developing metabolic syndrome following transplant, likely secondary to immunosuppressant use. Among those with metabolic syndrome, the rate of cardiovascular…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences